Post-marketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System.

[1]  Kelly L. Moore,et al.  Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants , 2020, MMWR. Morbidity and mortality weekly report.

[2]  Paige W. Lewis,et al.  Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines , 2018, Pediatrics.

[3]  F. Martinón-Torres,et al.  Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib). , 2017, Vaccine.

[4]  T. Vesikari,et al.  A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months , 2017, The Pediatric infectious disease journal.

[5]  S. Block,et al.  Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants , 2017, The Pediatric infectious disease journal.

[6]  G. Icardi,et al.  A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months. , 2016, Vaccine.

[7]  F. Destefano,et al.  Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). , 2015, Vaccine.

[8]  G. Liu,et al.  Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants , 2015, Pediatrics.

[9]  W Katherine Yih,et al.  Intussusception risk after rotavirus vaccination in U.S. infants. , 2014, The New England journal of medicine.

[10]  E. Belongia,et al.  Risk of intussusception after monovalent rotavirus vaccination. , 2014, The New England journal of medicine.

[11]  O. Lunacsek,et al.  Use of Combination Vaccines Is Associated With Improved Coverage Rates , 2007, The Pediatric infectious disease journal.

[12]  William DuMouchel,et al.  Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System , 1999 .

[13]  Nancy E. Messonnier,et al.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2018, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[14]  R. O’Neill,et al.  Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA’s Spontaneous Reports Database , 2002, Drug safety.